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INTRODUCTION
Recent results have shown that cotransplantation of human ex vivo expanded mesenchymal stem cells (MSCs) together with hematopoietic stem cells hastens hematopoietic recovery following a bone marrow (BM) transplantation in animal models [1] [2] [3] [4] and in humans [5] [6] [7] .
Human BM contains two cell compartments: the hematopoietic cell compartment and the stromal cell compartment that comprises MSCs [8, 9] . MSCs are able to give rise to multiple mesodermal tissue types, including bone, cartilage, tendon, muscles, cardiomyocytes, fat and brain [10] [11] [12] [13] [14] [15] [16] and a marrow stromal connective tissue which supports the differentiation of hematopoietic stem cells (HSCs) [17, 18] . However, MSCs are heterogeneous and little is known on the role of MSC subsets in the hematopoietic engraftment support and in their homing in various tissues [19] . Stro-1 antigen is present on CFU-F cells in adult human BM and potentially defines a MSC precursor sub-population [20] [21] [22] . The aim of the present study was to evaluate the role of ex vivo-expanded Stro-1 + and Stro-1 -MSCs on engraftment of human CD34 + cord blood cells in non obese diabetic/severe combined immunodeficiency (NOD/SCID) mice. Our data showed that the levels of human hematopoietic engraftment (as assessed by the presence of CD45, CD34, CD19 and CD11b cells) in the blood, spleen and mouse BM were higher when Stro-1 --derived cells were co-infused with CD34 + cells than when Stro-1 + -derived cells were used.
In a second step, we investigated the homing of expanded Biocytex, Marseille, France) as previously described [22] [23] . Briefly, anti-Stro-1-coated beads were added to the stromal cell suspension and positive cells were recovered with a magnetic particle concentrator (MPC-1) and washed 3 times before use.
FACS analysis
PE-labelled monoclonal antibodies used in this study were : anti-CD34, anti-CD45, 12 to 24 hours after irradiation, 1x10 6 expanded Stro-1 + or Stro-1 -MSCs resuspended in PBS were injected into the retro-orbital plexus of mice. 12 weeks after, mice were killed and blood, spleen, BM, lungs, heart, brain, liver, kidneys and leg muscles were collected for DNA extraction and PCR analysis to detect the presence of human MSCs DNA in these tissues.
DNA extraction and PCR analysis.
Genomic DNA for PCR analysis was prepared from tissues using phenol chloroform extraction after overnight incubation at 65°C in lysis buffer as previously described [24] . The DNA concentration and purity was estimated by optical density (OD) measurement. DNA analyses were performed by Real-time quantitative PCRs (Taq Man technology and ABI PRISM 7700). Amplification was performed using manufacturer-provided reagents following the standard recommended amplification conditions (Applied Biosytems, Foster City, CA) as previously described [25, 26] . One hundred nanogram of purified DNA from various tissues were amplified using TaqMan 
Immunohistology
The presence of GFP protein on eGFP-tranduced cells in mouse tissue sections was assessed by a rabbit anti-GFP antibody. The human origin of these cells on mouse tissues was assessed by an antibody directed against human -2 microglobulin. Tissues were fixed in 4% neutral buffered formaldehyde for 16 hours at room temperature and were then embedded in paraffin.
Sections (5 µm) were deparaffinised and rehydrated, then permeabilised for 5 min in 0.1%
Triton/PBS at room temperature. For eGFP detection, the immunocytochemistry was performed on a NexES IHC automat (Ventana, Illkirch, France) using DAB detection kit 
kit to make alcaline phosphatase reaction with FRED substrat followed by counterstaining with hematoxylin.
Statistical analysis:
Statistical analyses were performed using table curve software (SPSS, Paris, France).
The kinetics of human CD45 cell engrafment was evaluated by calculating areas under the curves (AUC) at different time points (3, 6, 9 and 12 weeks). Differences in CD45 + cell AUC between mouse groups were assessed using Man-Whitney Rank Sum Test. Other statistic tests were performed using Sigmastats software (SPSS .009 and p= 0.01 at week 6, 9 and 12 respectively ). The differences were also significant when the data of "CD34 + + Stro-1 -" group was compared to the "CD34 + + Stro-1 + " group (p= 0.005, p=0.004 and p= 0.02 at week 6, 9 and 12 respectively). No difference was observed between the groups "CD34 + + Stro-1 + " versus "CD34 + alone". These data of human CD45 In the spleen, there was a trend for higher percentages of CD45, CD19 and CD11b in the group "CD34 + + Stro-1 -" as compared to "CD34 + alone", but differences were not significant (p= 0.08, p= 0.4 and p=0.2 for CD45, CD19 and CD11b respectively). In blood, in addition to higher levels of CD45 as reported above (figure 1), there was a trend for an increase of CD19
and CD11b cell percentages in the group receiving "CD34 + + Stro-1 -" cells as compared to the group "CD34 + alone" (p= 0.2 for both CD19 and CD11b). In contrast, no significant differences in the percentages of human hematopoietic cells were observed between "CD34 + + Stro-1 + " and "CD34 + alone" groups.
III. Homing of Stro-1 + and Stro-1 -MSCs in mouse tissues.
In a second series of experiments, NOD/SCID mice receiving expanded Stro-1 + or Stro-1 -MSCs (without CD34 + cells) or no cells were sacrificed at 12 weeks and DNAs extracted from the BM, spleen, peripheral blood, brain, heart, liver, lungs, kidneys and leg muscles were analysed for the presence of specific human DNA by detection of human -GLOBIN gene.
The RAPSYN murine gene probe was used as an internal control to normalize the amount of human DNA as compared to murine DNA in quantitative PCR. The ratio of human/murine DNA copy numbers was expressed in numbers of human cells per 10000 murine cells.
Human Stro-1 + and Stro-1 -cell DNAs were found in variable amounts in BM, spleen, brain, heart, liver, lungs, kidneys and muscles, but not in blood ( The presence of eGFP-positive cells was thus assessed by a technique more sensitive, PCR: by this technique, a majority of the tissues were found positive. In particular, the BM that was found eGFP -negative by direct microscope examination and by FACS analysis, was actually eGFP-positive by PCR in 5/5 tested mice. In a baboon model, Devine et al [32] , also found positive homing of eGFP cells using a sensitive quantitative PCR technique. These results were also obtained by one of us [36] in irradiated macaques.
IV. Injection into NOD
Very rare pluripotent stem cells persist into the stromal cell compartment of adult bone marrow [37, 38] . In given circumstances (lesion, new environment) they may proliferate and differentiate. Interestingly, in our non human primate model [36] 
